Work

Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non–small cell lung cancer: Results from a randomized trial

Year: 2022

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic and Cardiovascular Surgery

DOI: 10.1016/j.jtcvs.2022.07.017

Authors: Benjamin Lee, Nathan Mynard, Abu Nasar, Jonathan Villena-Vargas, Oliver Chow, Sebron Harrison, Brendon Stiles, Jeffrey Port, Nasser Altorki

Institutions: Weill Cornell Medicine, Albert Einstein College of Medicine, Montefiore Health System

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: AstraZeneca

OpenAlex ID: W4292156490

FWCI: 2.529

Cites: 20

Cited by: 20

Related to: 10